REBONOX

Serial Number 97315223
602

Registration Progress

Application Filed
Mar 16, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: REBONOX
Previous Owner: Medytox Inc.
Classes: 005

Trademark Image

REBONOX

Basic Information

Serial Number
97315223
Filing Date
March 16, 2022
Abandonment Date
April 5, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Apr 22, 2023
Classes
005

Rights Holder

Medytox Inc.

03
Address
78, Gangni 1-gil, Ochang-eup
Cheongwon-gu, Cheongju-si
Chungcheongbuk-do 28126
KR

Ownership History

Medytox Inc.

Original Applicant
03
Chungcheongbuk-do KR

Legal Representation

Attorney
Mark J. Liss

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

9 events
Date Code Type Description Documents
Apr 24, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Apr 22, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Apr 22, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Jan 4, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 4, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 4, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 28, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 22, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 19, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Chemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, eye blinking, neuropathy pain and pelvic pain; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for peripheral nervous system; bacterial poisons; pharmacological preparations for skin care, namely, pharmaceutical preparations for skin care; pharmaceutical agents for epidermis; injectable dermal fillers; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; biological preparations for medical or veterinary purposes for the treatment and prevention of neurological disorders and muscle dystonia; vaccines; medicated lotions for skin, hair, sunburn, face, body; implantable medicines for treating antiaging, neurological disorders and muscle dystonia; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, eye blinking, neuropathy pain and pelvic pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, eye blinking, neuropathy pain and pelvic pain; medicinal infusions for treating antiaging, neurological disorders and muscle dystonia
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005